<DOC>
	<DOCNO>NCT00003130</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness paclitaxel treat woman recurrent solid tumor .</brief_summary>
	<brief_title>Paclitaxel Treating Women With Recurrent Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate relationship body surface area ( BSA ) toxic effect , BSA pharmacokinetics , pharmacokinetics toxic effect woman recurrent solid tumor receive fix total dose paclitaxel . II . Determine toxic effect paclitaxel patient . III . Assess pharmacokinetics paclitaxel patient . OUTLINE : Patients receive single fix dose intravenous paclitaxel 3 hour day 1 . Blood sample must draw prior first paclitaxel infusion 1 , 6 , 24 hour start infusion course 1 . Treatment course intravenous paclitaxel repeat every 3 week discretion treat physician . Patients evaluated response second course . Patients follow discretion physician . PROJECTED ACCRUAL : A total 50 patient accrued 13 month .</detailed_description>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven recurrent adult solid tumor Must measurable evaluable disease No known bone marrow metastasis PATIENT CHARACTERISTICS : Age : 18 Sex : Women Performance Status : Zubrod 02 Life Expectancy : Not specify Hematopoietic : Absolute granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin le 1.5 mg/dL SGOT le 2.0 time upper limit normal Renal : Creatinine great 1.5 time upper limit normal Other : Concurrently active secondary malignancy allow PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior paclitaxel therapy No 1 prior chemotherapy regimen metastatic disease At least 4 week since chemotherapy Greater 6 week since nitrosoureas , melphalan , mitomycin Endocrine therapy : Not specify Radiotherapy : At least 4 week since radiotherapy No prior whole pelvic radiation Surgery : At least 4 week since major surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>